Articolul precedent |
Articolul urmator |
326 0 |
SM ISO690:2012 SUREV, Artiom, ABRAŞ, Marcel, GRIB, Andrei, MOISEEVA, Anna. Reperfuzie imediată versus amânată la pacienții cu nstemi și risc intermediar sau mic. In: Congresul consacrat aniversării a 75-a de la fondarea Universității de Stat de Medicină şi Farmacie „Nicolae Testemiţanu”, 21-23 octombrie 2020, Chişinău. Chişinău: USMF, 2020, p. 267. |
EXPORT metadate: Google Scholar Crossref CERIF DataCite Dublin Core |
Congresul consacrat aniversării a 75-a de la fondarea Universității de Stat de Medicină şi Farmacie „Nicolae Testemiţanu” 2020 | ||||||
Congresul "Congresul consacrat aniversării a 75-a de la fondarea Universității de Stat de Medicină şi Farmacie „Nicolae Testemiţanu”" Chişinău, Moldova, 21-23 octombrie 2020 | ||||||
|
||||||
Pag. 267-267 | ||||||
|
||||||
Descarcă PDF | ||||||
Rezumat | ||||||
Background. An immediate repefusion for treating high-risk NSTEMI patients is the gold standard. Treatment of intermediate to low risk patients is not always so straightforward. The rush to perform revascularization can lead to poorer results than intervention performed on an stabilized atherosclerotic plaque. Objective of the study. To compare the six months clinical outcome of immediate versus delayed reperfusion strategy in low and intermediate NSTEMI patients. Material and Methods. The study included two groups of 126 patients with NSTEMI and GRACE score below 140 who underwent angioplasty: in the first 72 hours from the onset of symptoms and in 72 hours - 30 days. Both groups were monitored for six months, after which it was analyzed: composite of death, new myocardial infarction, repeat revascularization and new onset of angina. Results. In the first group, over six months of follow-up, 2 patients (1.6%) died, one of the patients during hospitalization due to heart failure, and the second patient died suddenly in the third month. In the second group, not a single patient died (0%). (p>0.05) New myocardial infarction developed in group I in 4 patients (3.2%), in group II there were no cases of new myocardial infarction (0%). (p>0.05) Repeated revascularization in group I was required in 7 patients (5.6%), in group II no one needed repeated revascularization (0%). (p<0.05) New onset of angina were noted in group I in 46 patients (37.1%), in group II were noted in 8 (6.3%) cases. (p<0.001) Conclusion. Immediate reperfusion of intermediate and low risc NSTEMI patients does not reduce the likelihood of developing myocardial infarction or death in the first six months, but it increases the incidence of new onset of angina and repeated revascularization. |
||||||
Cuvinte-cheie NSTEMI, time of reperfusion, angioplasty, intermediate risc, low risc, NSTEMI, timp de reperfuzie, angioplastie, risc intermediar, risc mic |
||||||
|